FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2765206651> ?p ?o ?g. }

• W2765206651 abstract "In recurrent breast cancer, the tumor phenotype, as assessed by estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor 2 (HER2) status, occasionally changes. This change, in addition to the Ki67 index were evaluated at sites of recurrence and the correlation between changes in tumor phenotype and survival were assessed in breast cancer patients. Comparisons in pathological parameters between primary and metastatic lesions were drawn between ER, PR, HER2, and the Ki67 index in 70 patients with recurrent breast cancer. The association between changes in tumor phenotype and patient survival was assessed. The hormone receptor status changed from positive, in the primary lesions, to negative, in the metastatic lesions in 19.8% (ER) and 39.5% (PR) of patients, respectively. Conversion from negative to positive status was confirmed in 27.2% (ER) and 31.2% (PR) of patients, respectively. A change in HER2 status from negative (primary lesion) to positive (metastatic lesion) occurred in seven patients (10%). The mean Ki67 index of primary lesions with positive hormone receptor status was significantly lower than at sites of recurrence with any hormone receptor status, from 10.9±9.8 standard deviation (SD) to 22.9±18.6 (P=0.031) and 12.2±10.5 SD to 27.4±20.9 (P=0.023), for ER and PR, respectively. The mean overall survival of patients with ER status conversion from positive to negative was 7.4±1.2 standard error (SE) years, and 14.8±1.4 SE years for patients who retained positive ER status (P=0.005, log-rank), with a hazard ratio of 3.44 (95% confidence interval, 1.36-8.33). This difference in survival based upon change in ER status was similarly observed in patients with PR status conversion in the same direction. Thus, ER and PR status conversion at the time of recurrence strongly impact survival, particularly if the change is from positive (primary lesion) to negative (metastatic lesion). Monitoring the biological behavior of breast cancer may benefit a patient by allowing for a novel personalized treatment strategy." @default.
• W2765206651 created "2017-11-10" @default.
• W2765206651 creator A5016171700 @default.
• W2765206651 creator A5039588134 @default.
• W2765206651 creator A5042998334 @default.
• W2765206651 creator A5049201390 @default.
• W2765206651 creator A5056763447 @default.
• W2765206651 creator A5061945229 @default.
• W2765206651 creator A5064636550 @default.
• W2765206651 creator A5064838609 @default.
• W2765206651 creator A5068279638 @default.
• W2765206651 date "2017-10-19" @default.
• W2765206651 modified "2023-10-17" @default.
• W2765206651 title "Alterations in three biomarkers (estrogen receptor, progesterone receptor and human epidermal growth factor 2) and the Ki67 index between primary and metastatic breast cancer lesions" @default.
• W2765206651 cites W1482458857 @default.
• W2765206651 cites W1570399322 @default.
• W2765206651 cites W1673285127 @default.
• W2765206651 cites W1837535271 @default.
• W2765206651 cites W1982705558 @default.
• W2765206651 cites W1983986759 @default.
• W2765206651 cites W2000468408 @default.
• W2765206651 cites W2000536166 @default.
• W2765206651 cites W2009615898 @default.
• W2765206651 cites W2018280825 @default.
• W2765206651 cites W2032338743 @default.
• W2765206651 cites W2044702943 @default.
• W2765206651 cites W2063874882 @default.
• W2765206651 cites W2077966621 @default.
• W2765206651 cites W2112695753 @default.
• W2765206651 cites W2113233663 @default.
• W2765206651 cites W2126486896 @default.
• W2765206651 cites W2130900820 @default.
• W2765206651 cites W2135890715 @default.
• W2765206651 cites W2137853125 @default.
• W2765206651 cites W2150134401 @default.
• W2765206651 cites W2155391972 @default.
• W2765206651 cites W2166810107 @default.
• W2765206651 cites W2231000545 @default.
• W2765206651 cites W4299561746 @default.
• W2765206651 doi "https://doi.org/10.3892/br.2017.1003" @default.
• W2765206651 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5702957" @default.
• W2765206651 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29188058" @default.
• W2765206651 hasPublicationYear "2017" @default.
• W2765206651 type Work @default.
• W2765206651 sameAs 2765206651 @default.
• W2765206651 citedByCount "8" @default.
• W2765206651 countsByYear W27652066512018 @default.
• W2765206651 countsByYear W27652066512019 @default.
• W2765206651 countsByYear W27652066512020 @default.
• W2765206651 countsByYear W27652066512021 @default.
• W2765206651 countsByYear W27652066512022 @default.
• W2765206651 countsByYear W27652066512023 @default.
• W2765206651 crossrefType "journal-article" @default.
• W2765206651 hasAuthorship W2765206651A5016171700 @default.
• W2765206651 hasAuthorship W2765206651A5039588134 @default.
• W2765206651 hasAuthorship W2765206651A5042998334 @default.
• W2765206651 hasAuthorship W2765206651A5049201390 @default.
• W2765206651 hasAuthorship W2765206651A5056763447 @default.
• W2765206651 hasAuthorship W2765206651A5061945229 @default.
• W2765206651 hasAuthorship W2765206651A5064636550 @default.
• W2765206651 hasAuthorship W2765206651A5064838609 @default.
• W2765206651 hasAuthorship W2765206651A5068279638 @default.
• W2765206651 hasBestOaLocation W27652066511 @default.
• W2765206651 hasConcept C121608353 @default.
• W2765206651 hasConcept C126322002 @default.
• W2765206651 hasConcept C142724271 @default.
• W2765206651 hasConcept C143998085 @default.
• W2765206651 hasConcept C170493617 @default.
• W2765206651 hasConcept C204232928 @default.
• W2765206651 hasConcept C23589133 @default.
• W2765206651 hasConcept C2775930923 @default.
• W2765206651 hasConcept C2776085573 @default.
• W2765206651 hasConcept C2776362946 @default.
• W2765206651 hasConcept C2777164284 @default.
• W2765206651 hasConcept C2779013556 @default.
• W2765206651 hasConcept C2779438470 @default.
• W2765206651 hasConcept C2780283643 @default.
• W2765206651 hasConcept C2910938049 @default.
• W2765206651 hasConcept C530470458 @default.
• W2765206651 hasConcept C71924100 @default.
• W2765206651 hasConcept C84606932 @default.
• W2765206651 hasConcept C98717036 @default.
• W2765206651 hasConceptScore W2765206651C121608353 @default.
• W2765206651 hasConceptScore W2765206651C126322002 @default.
• W2765206651 hasConceptScore W2765206651C142724271 @default.
• W2765206651 hasConceptScore W2765206651C143998085 @default.
• W2765206651 hasConceptScore W2765206651C170493617 @default.
• W2765206651 hasConceptScore W2765206651C204232928 @default.
• W2765206651 hasConceptScore W2765206651C23589133 @default.
• W2765206651 hasConceptScore W2765206651C2775930923 @default.
• W2765206651 hasConceptScore W2765206651C2776085573 @default.
• W2765206651 hasConceptScore W2765206651C2776362946 @default.
• W2765206651 hasConceptScore W2765206651C2777164284 @default.
• W2765206651 hasConceptScore W2765206651C2779013556 @default.
• W2765206651 hasConceptScore W2765206651C2779438470 @default.
• W2765206651 hasConceptScore W2765206651C2780283643 @default.
• W2765206651 hasConceptScore W2765206651C2910938049 @default.
• W2765206651 hasConceptScore W2765206651C530470458 @default.
• W2765206651 hasConceptScore W2765206651C71924100 @default.
• W2765206651 hasConceptScore W2765206651C84606932 @default.

• next